Literature DB >> 16880252

Presentation and echocardiographic markers of neonatal hypertensive cardiomyopathy.

Amy L Peterson1, Peter C Frommelt, Kathy Mussatto.   

Abstract

BACKGROUND: Systemic hypertension is a rare but important cause of neonatal heart failure. It is critical that this etiology be recognized and distinguished from other causes of myocardial dysfunction in young infants, because diagnostic studies, treatments, and prognoses are quite different.
METHODS: Between 1991 and 2005, 11 neonates were diagnosed as having neonatal cardiomyopathy and systemic hypertension through retrospective review of the Children's Hospital of Wisconsin database.
RESULTS: All infants in the cohort were found to have systemic hypertension (blood pressure of > 95th percentile for gestational age and weight). Causes included renovascular disease (n = 9), aortic obstruction secondary to thrombus (n = 1), and steroid use (n = 1). Echocardiography was performed at presentation for all patients because of cardiomegaly and/or hypertension. Echocardiographic findings were consistently striking for (1) left ventricular systolic dysfunction without chamber dilation, (2) concentric left ventricular hypertrophy, (3) left atrial dilation, and (4) aortomegaly. No anatomic aortic arch obstruction was identified, but Doppler findings for the descending thoracic aorta were uniformly consistent with elevated systemic vascular resistance. One patient died as a result of overwhelming thrombotic disease; all other patients responded to afterload reduction therapy with normalization of left ventricular systolic function during infancy.
CONCLUSIONS: Hypertensive cardiomyopathy can present in neonates with nonspecific symptoms and systemic hypertension. Because sometimes hypertension in infants is ignored or misinterpreted as agitation, echocardiography can provide critical markers of the disease.

Entities:  

Mesh:

Year:  2006        PMID: 16880252     DOI: 10.1542/peds.2006-0631

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

1.  Postrenal biopsy AVM leading to severe hypertension and dilated cardiomyopathy.

Authors:  Nao Sasaki; Umesh C Joashi; Marcela Vergara; Jeffrey M Saland; Barry A Love
Journal:  Pediatr Nephrol       Date:  2009-08-04       Impact factor: 3.714

2.  Unmasking of neonatal renovascular hypertension by milrinone used for cardiac dysfunction.

Authors:  Prema Ramaswamy; Susan Schulman; Panayot Filipov; Juan C Kupferman
Journal:  Pediatr Cardiol       Date:  2011-06-09       Impact factor: 1.655

3.  Systemic hypertension requiring treatment in the neonatal intensive care unit.

Authors:  Raj Sahu; Hariyadarshi Pannu; Robert Yu; Sanjay Shete; John T Bricker; Monesha Gupta-Malhotra
Journal:  J Pediatr       Date:  2013-02-07       Impact factor: 4.406

4.  Neonatal circulatory failure due to acute hypertensive crisis: clinical and echocardiographic clues.

Authors:  Jacoba Louw; Stephen Brown; Liesbeth Thewissen; Anne Smits; Benedicte Eyskens; Ruth Heying; Bjorn Cools; Elena Levtchenko; Karel Allegaert; Marc Gewillig
Journal:  Cardiovasc J Afr       Date:  2013-04       Impact factor: 1.167

Review 5.  Novelty in hypertension in children and adolescents: focus on hypertension during the first year of life, use and interpretation of ambulatory blood pressure monitoring, role of physical activity in prevention and treatment, simple carbohydrates and uric acid as risk factors.

Authors:  Mirella Strambi; Marco Giussani; Maria Amalia Ambruzzi; Paolo Brambilla; Ciro Corrado; Ugo Giordano; Claudio Maffeis; Silvio Maringhin; Maria Chiara Matteucci; Ettore Menghetti; Patrizia Salice; Federico Schena; Pietro Strisciuglio; Giuliana Valerio; Francesca Viazzi; Raffaele Virdis; Simonetta Genovesi
Journal:  Ital J Pediatr       Date:  2016-07-16       Impact factor: 2.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.